Elevance Health, Inc. (ELV) Financials
ELV Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 111.9 billion | 71.2 billion |
| 2023-12-31 | 108.9 billion | 69.5 billion |
| 2023-09-30 | 110.5 billion | 71.9 billion |
| 2023-06-30 | 109.2 billion | 70.9 billion |
ELV Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | 1.7 billion | 62.0 million |
| 2023-12-31 | -3.3 billion | 72.0 million |
| 2023-09-30 | 2.3 billion | 78.0 million |
| 2023-06-30 | 1.6 billion | 78.0 million |
ELV Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 2.2 billion |
| 2023-12-31 | 831.0 million |
| 2023-09-30 | 1.3 billion |
| 2023-06-30 | 1.9 billion |
ELV Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 35.8 billion | - | - |
| 2023-12-31 | 36.1 billion | - | - |
| 2023-09-30 | 38.7 billion | 24.0 billion | - |
| 2023-06-30 | 10.0 billion | 24.9 billion | - |
ELV Shares Outstanding
ELV Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 279.0 million | - | - | - |
| 2023-12-31 | 326.0 million | - | - | - |
| 2023-09-30 | 319.0 million | - | - | - |
| 2023-06-30 | 350.0 million | - | 4.8 billion | - |
ELV Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 42.6 billion | 3.8 billion |
| 2023-12-31 | 42.6 billion | 4.8 billion |
| 2023-09-30 | 42.8 billion | 4.6 billion |
| 2023-06-30 | 43.7 billion | 4.3 billion |
ELV
List: Contenders
Price: $536.96
Dividend Yield: 1.23%
Forward Dividend Yield: 1.21%
Payout Ratio: 25.86%
Dividend Per Share: 6.52 USD
Earnings Per Share: 25.22 USD
P/E Ratio: 20.04
Exchange: NYQ
Sector: Healthcare
Industry: Healthcare Plans
Volume: 1.2 million
Market Capitalization: 123.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 16.69%
DGR5: 13.77%
DGR10: 16.01%